BAUSCH FDA Approval NDA 021392

NDA 021392

BAUSCH

FDA Drug Application

Application #021392

Documents

Letter2007-05-01
Label2003-02-06
Label2004-04-05
Label2007-05-01
Label2015-04-14
Review2005-06-27
Review2007-07-06
Letter2004-04-07
Letter2010-11-30
Letter2015-03-25
Label2010-11-22
Letter2016-11-22
Label2016-11-21

Application Sponsors

NDA 021392BAUSCH

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004
Prescription005
Prescription006

Application Products

001TABLET, EXTENDED RELEASE;ORAL120MG1CARDIZEM LADILTIAZEM HYDROCHLORIDE
002TABLET, EXTENDED RELEASE;ORAL180MG1CARDIZEM LADILTIAZEM HYDROCHLORIDE
003TABLET, EXTENDED RELEASE;ORAL240MG1CARDIZEM LADILTIAZEM HYDROCHLORIDE
004TABLET, EXTENDED RELEASE;ORAL300MG1CARDIZEM LADILTIAZEM HYDROCHLORIDE
005TABLET, EXTENDED RELEASE;ORAL360MG1CARDIZEM LADILTIAZEM HYDROCHLORIDE
006TABLET, EXTENDED RELEASE;ORAL420MG1CARDIZEM LADILTIAZEM HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2003-02-06STANDARD
EFFICACY; EfficacySUPPL2AP2004-04-02STANDARD
LABELING; LabelingSUPPL10AP2007-04-27STANDARD
LABELING; LabelingSUPPL14AP2010-11-23UNKNOWN
LABELING; LabelingSUPPL19AP2015-03-23STANDARD
LABELING; LabelingSUPPL20AP2016-11-18STANDARD

Submissions Property Types

SUPPL14Null7
SUPPL19Null7
SUPPL20Null7

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
004PrescriptionAB
005PrescriptionAB
006PrescriptionAB

CDER Filings

BAUSCH
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21392
            [companyName] => BAUSCH
            [docInserts] => ["",""]
            [products] => [{"drugName":"CARDIZEM LA","activeIngredients":"DILTIAZEM HYDROCHLORIDE","strength":"120MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"CARDIZEM LA","activeIngredients":"DILTIAZEM HYDROCHLORIDE","strength":"180MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"CARDIZEM LA","activeIngredients":"DILTIAZEM HYDROCHLORIDE","strength":"240MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"CARDIZEM LA","activeIngredients":"DILTIAZEM HYDROCHLORIDE","strength":"300MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"CARDIZEM LA","activeIngredients":"DILTIAZEM HYDROCHLORIDE","strength":"360MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"CARDIZEM LA","activeIngredients":"DILTIAZEM HYDROCHLORIDE","strength":"420MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"11\/18\/2016","submission":"SUPPL-20","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/021392s020lbl.pdf\"}]","notes":""},{"actionDate":"03\/23\/2015","submission":"SUPPL-19","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/021392s019lbl.pdf\"}]","notes":""},{"actionDate":"11\/23\/2010","submission":"SUPPL-14","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/021392s014lbl.pdf\"}]","notes":""},{"actionDate":"04\/27\/2007","submission":"SUPPL-10","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/021392s010lbl.pdf\"}]","notes":""},{"actionDate":"04\/02\/2004","submission":"SUPPL-2","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/21392se1-002_cardizem_lbl.pdf\"}]","notes":""},{"actionDate":"02\/06\/2003","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/021392lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"CARDIZEM LA","submission":"DILTIAZEM HYDROCHLORIDE","actionType":"120MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"CARDIZEM LA","submission":"DILTIAZEM HYDROCHLORIDE","actionType":"180MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"CARDIZEM LA","submission":"DILTIAZEM HYDROCHLORIDE","actionType":"240MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"CARDIZEM LA","submission":"DILTIAZEM HYDROCHLORIDE","actionType":"300MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"CARDIZEM LA","submission":"DILTIAZEM HYDROCHLORIDE","actionType":"360MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"CARDIZEM LA","submission":"DILTIAZEM HYDROCHLORIDE","actionType":"420MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2016-11-18
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.